Howard W. Rogers

TL;DR: This study is a thorough nationwide estimate of the incidence of nonmelanoma skin cancer and provides evidence of continued increases in numbers of skin cancer diagnoses and affected patients in the United States.

TL;DR: The number of skin cancers in Medicare beneficiaries increased dramatically over the years 1992 to 2006, due mainly to an increase in the number of affected individuals.

TL;DR: The number of skin cancer treatment procedures increased substantially from 1996 to 2008, as did overall costs to Medicare and Dermatologists treated the vast majority of skin cancers in the Medicare population, using a mix of treatment modalities.

TL;DR: This review better familiarizes the medical community with the practice of MMS, its utilization and capabilities, differences from wide excision and vertical section pathology, and cost‐effectiveness, and guides practitioners in the process of appropriately evaluating and determining when patients with skin cancer might be appropriate candidates for MMS.

TL;DR: In this article, the authors proposed a standard definition of local recurrence after surgical treatment of nonmelanoma skin cancer and proposed an acceptable surveillance period and tracking methods, based on the modified Delphi process.